Etanercept - CISMeF

Preferred Label : Etanercept;

MeSH definition : A recombinant version of soluble human TNF receptor that binds specifically to TUMOR NECROSIS FACTOR and inhibits its binding with endogenous TNF receptors. It prevents the inflammatory effect of TNF and is used to treat RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS and ANKYLOSING SPONDYLITIS.; A recombinant version of soluble human TNF receptor fused to an IgG FC fragment that binds specifically to TUMOR NECROSIS FACTOR and inhibits its binding with endogenous TNF receptors. It prevents the inflammatory effect of TNF and is used to treat RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS and ANKYLOSING SPONDYLITIS.;

CISMeF synonym : 001, TNR; Protein, TNFR-Fc Fusion;

MeSH hyponym : recombinant human dimeric TNF receptor type II-IgG fusion protein; TNFR-Fc fusion protein; TNF receptor type II-IgG fusion protein; Enbrel; Fusion Protein, TNFR-Fc; TNFR Fc Fusion Protein; TNR 001; TNT Receptor Fusion Protein; TNTR-Fc; TNR-001; TNR001; TNF Receptor Type II IgG Fusion Protein; Recombinant Human Dimeric TNF Receptor Type II IgG Fusion Protein;

MeSH Related Number : 185243-69-0;

Wikipedia link : https://en.wikipedia.org/wiki/Etanercept;

Is substance : O;

UNII : OP401G7OJC;

Details

Origin ID

D000068800;

UMLS CUI

C0717758;

ATC code(s)
- etanercept [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Pharmacological action(s)
- anti-inflammatory agents, non-steroidal [MeSH Descriptor]
- gastrointestinal agents [MeSH Descriptor]
- immunosuppressive agents [MeSH Descriptor]
Record concept(s)
- Enbrel [MeSH concept]
- Erelzi [MeSH concept]
- Etanercept-szzs [MeSH concept]
- TNF receptor type II-IgG fusion protein [MeSH concept]
- TNFR-Fc fusion protein [MeSH concept]
- etanercept [MeSH concept]
- recombinant human dimeric TNF receptor type II-IgG fusion protein [MeSH concept]
Related MeSH Supplementary Concept(s)
- GP2015 [MeSH Supplementary Concept]
- etanercept biosimilar SB4 [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Product containing etanercept (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Etanercept [NCIt concept]
- Etanercept [LOINC component]
- Etanercept (substance) [SNOMED CT concept]
- Product containing etanercept (medicinal product) [SNOMED CT concept]
- etanercept [ATC Code]
Validated automatic mappings to BTNT
- etanercept [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients